These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3071825)

  • 1. [Analysis of IL-3 receptor using monoclonal antibodies].
    Ohta Y; Sugawara M
    Tanpakushitsu Kakusan Koso; 1988 Sep; 33(11):1819-23. PubMed ID: 3071825
    [No Abstract]   [Full Text] [Related]  

  • 2. High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61.
    Lowenthal JW; Corthésy P; Tougne C; Lees R; MacDonald HR; Nabholz M
    J Immunol; 1985 Dec; 135(6):3988-94. PubMed ID: 3934270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High- and low-affinity interleukin 2 receptors: distinctive effects of monoclonal antibodies.
    Fujii M; Sugamura K; Nakai S; Tanaka Y; Tozawa H; Hinuma Y
    J Immunol; 1986 Sep; 137(5):1552-6. PubMed ID: 3091684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on T lymphocyte activation. II. Monoclonal antibody inhibiting the capacity of rat T lymphoblasts to absorb and to respond to IL-2: an anti-IL-2 receptor antibody?
    Osawa H; Diamantstein T
    Immunology; 1983 Mar; 48(3):617-21. PubMed ID: 6600707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel binding assay to assess specificity of monoclonal antibodies.
    Warren HS; Bettadapura J
    J Immunol Methods; 2005 Oct; 305(1):33-8. PubMed ID: 16125193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL 2 receptor functions: a putative anti-IL 2 receptor antibody.
    Osawa H; Diamantstein T
    J Immunol; 1984 May; 132(5):2445-50. PubMed ID: 6425405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune effector cells. IX. Inhibition of adoptive transfer of autoimmune encephalomyelitis with a monoclonal antibody specific for interleukin 2 receptors.
    Hayosh NS; Swanborg RH
    J Immunol; 1987 Jun; 138(11):3771-5. PubMed ID: 3108373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The murine IL 2 receptor. II. Monoclonal anti-IL 2 receptor antibodies as specific inhibitors of T cell function in vitro.
    Malek TR; Ortega G; Jakway JP; Chan C; Shevach EM
    J Immunol; 1984 Oct; 133(4):1976-82. PubMed ID: 6432904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2.
    Kaye J; Gillis S; Mizel SB; Shevach EM; Malek TR; Dinarello CA; Lachman LB; Janeway CA
    J Immunol; 1984 Sep; 133(3):1339-45. PubMed ID: 6235287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody inhibiting leucocyte adhesion blocks induction of IL-2 production but not IL-2 receptor expression.
    Lindqvist C; Patarroyo M; Beatty PG; Wigzell H
    Immunology; 1987 Apr; 60(4):579-84. PubMed ID: 3108139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
    Weston KM; Yeh ET; Sy MS
    J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics of a monoclonal antibody that binds specifically to rat T lymphoblasts and inhibits IL 2 receptor functions.
    Osawa H; Diamantstein T
    J Immunol; 1983 Jan; 130(1):51-5. PubMed ID: 6401187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
    Taniguchi N; Miyawaki T; Yachie A
    Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal anti-IL-2 receptor antibody in primate renal transplantation.
    Shapiro ME; Kirkman RL; Reed MH; Puskas JD; Mazoujian G; Letvin NL; Carpenter CB; Milford EL; Waldmann TA; Strom TB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):594-8. PubMed ID: 3103282
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulation of interleukin-3 dependent cell growth by specific antibody.
    Kinnaird A; Garland J
    Immunology; 1985 Jul; 55(3):457-61. PubMed ID: 3926635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype.
    Kupiec-Weglinski JW; Di Stefano R; Stunkel KG; Grutzmann R; Theisen P; Araneda D; Tilney NL; Diamantstein T
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):272-5. PubMed ID: 3126574
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional blocking of the interleukin-2 receptor (IL-2R) may be important in the efficacy of IL-2R antibody therapy.
    Tellides G; Dallman MJ; Kupiec-Weglinski JW; Diamantstein T; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):4231-3. PubMed ID: 3118538
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistochemical localization of cells reacting with monoclonal antibodies directed against the interleukin-2 receptor of murine, rat and human origin.
    Takacs L; Osawa H; Törö I; Diamantstein T
    Clin Exp Immunol; 1985 Jan; 59(1):37-44. PubMed ID: 3918819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses.
    Malek TR; Robb RJ; Shevach EM
    J Immunol; 1983 Feb; 130(2):747-55. PubMed ID: 6184403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interleukin 2 receptor and its physiology. Implications for combatting autoimmune diseases and transplant rejections.
    Diamantstein T
    Behring Inst Mitt; 1987 Jun; (81):73-87. PubMed ID: 3115248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.